Refinement of IKZF1 recombination hotspots in pediatric BCP-ALL patients.
Authors:
- Udo Zur StadtUSUdo Zur Stadt
- Gabriele EscherichGEGabriele Escherich
- Julia HofmannJHJulia Hofmann
- Renata BinatoRBRenata Binato
- Thayana Conceição BarbosaTBThayana Conceição Barbosa
- Mariana EmerencianoMEMariana Emerenciano
- Maria S Pombo-De-OliveiraMPMaria S Pombo-De-Oliveira
- Martin HorstmannMHMartin Horstmann
- Rolf MarschalekRMRolf Marschalek
- 5 May 2013
- journal article
- Vol. 3 (2) , 165-73
Abstract
Chromosomal translocations resulting in chimeric fusion genes are prototypic for pediatric leukemia patients. The most known fusions are ETV6-RUNX1 or BCR-ABL1 in B-cell progenitor (BCP)-ALL, and rearrangements of MLL in pediatric ALL and AML. Genome-wide sequencing projects have revealed additional, recurrent gene mutations in B cell malignancies. One of these mutations comprises the IKZF1 gene, encoding the IKAROS transcription factor which is one of the essential transcription factors driving lymphoid development. IKZF1 deletions were first identified by SNP arrays in ALL patients, and later identified with a high prevalence in BCR-ABL1(+) patients. IKZF1 deletions turned out to be an independent prognostic marker associated with a poor outcome. Here, we characterized IKZF1 deletions in pediatric BCP-ALL patients by combining MLPA mapping experiments with long distance inverse PCR. The aim of our study was also to compare existing methods with our approach. Our attempt confirmed many of the existing data but revealed a more complex pattern of recombination sites, including a total of 4 recombination hotspots. This extended knowledge was translated into a novel, multiplex PCR assay that allows to perform IKZF1 deletion analyses by using a 2-tube PCR approach.Keywords
This publication has 20 references indexed in Scilit:
- Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemiaHaematologica, 2012
- The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemiaBlood Reviews, 2012
- Highly sensitive MRD tests for ALL based on the IKZF1 Δ3–6 microdeletionLeukemia, 2011
- How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemiaCurrent Opinion in Pediatrics, 2011
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyThe Lancet Oncology, 2009
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of IkarosNature, 2008
- High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progressionLeukemia, 2007
- Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaNature, 2007
- The ikaros gene is required for the development of all lymphoid lineagesCell, 1994
- Ikaros, an Early Lymphoid-Specific Transcription Factor and a Putative Mediator for T Cell CommitmentScience, 1992